Both in Pharmaceuticals
SELLAS Life Sciences Group vs Stoke Therapeutics
Over the past year SLS returned +450.6% and STOK returned +8.3%; their daily moves had a correlation of 0.23.
SLS +450.6% STOK +8.3%Growth of $1, one year, split-adjusted
| Metric | SLS | STOK |
|---|---|---|
| Price | $9.14 | $27.45 |
| Market cap | $1.85B | $1.77B |
| Today | +3.04% | +1.70% |
| 1 month | −19.4% | +12.6% |
| 6 months | +77.5% | −17.5% |
| Year to date | +142.4% | −13.5% |
| 1 year | +410.6% | +5.2% |
| Revenue growth (YoY) | — | +5.9% |
| Gross margin | — | 100.0% |
| Net margin | — | −654.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 62.8× |
| Net cash | $138.3M | $319.2M |
| Dividend yield | — | — |
| Volatility (60d) | 97.0% | 47.9% |
| Short % of float | 27.0% | 18.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).